GUAIFENESIN, DEXTROMETHORPHAN HBR

N/A

Manufactured by CVS Pharmacy

199 FDA adverse event reports analyzed

Last updated: 2026-04-15

About GUAIFENESIN, DEXTROMETHORPHAN HBR

GUAIFENESIN, DEXTROMETHORPHAN HBR is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by CVS Pharmacy. The most commonly reported adverse reactions for GUAIFENESIN, DEXTROMETHORPHAN HBR include COVID-19, DYSPNOEA, DISEASE RECURRENCE, ASTHENIA, COUGH. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for GUAIFENESIN, DEXTROMETHORPHAN HBR.

Top Adverse Reactions

COVID 1910 reports
DYSPNOEA8 reports
DISEASE RECURRENCE7 reports
ASTHENIA6 reports
COUGH5 reports
PNEUMONIA5 reports
DIARRHOEA4 reports
FALL4 reports
FATIGUE4 reports
HEADACHE4 reports
NASOPHARYNGITIS4 reports
NAUSEA4 reports
PAIN4 reports
PAIN IN EXTREMITY4 reports
WEIGHT DECREASED4 reports
BLOOD PRESSURE INCREASED3 reports
DIZZINESS3 reports
FEELING ABNORMAL3 reports
MALAISE3 reports
PARAESTHESIA3 reports
URINARY TRACT INFECTION3 reports
ATRIAL FIBRILLATION2 reports
BALANCE DISORDER2 reports
BRONCHITIS2 reports
CONDITION AGGRAVATED2 reports
CONFUSIONAL STATE2 reports
DEPRESSION2 reports
FEELING HOT2 reports
FLUSHING2 reports
HERNIA2 reports
HOSPITALISATION2 reports
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION2 reports
INFLUENZA LIKE ILLNESS2 reports
MEMORY IMPAIRMENT2 reports
MULTIPLE ALLERGIES2 reports
OFF LABEL USE2 reports
PRODUCT DOSE OMISSION ISSUE2 reports
PRODUCT USE IN UNAPPROVED INDICATION2 reports
PRURITUS2 reports
PYREXIA2 reports
SEASONAL ALLERGY2 reports
THROAT TIGHTNESS2 reports
UNEVALUABLE EVENT2 reports
URTICARIA2 reports
VERTIGO2 reports
VIRAL INFECTION2 reports
ABDOMINAL HERNIA1 reports
ABNORMAL BEHAVIOUR1 reports
ABNORMAL DREAMS1 reports
ACCIDENTAL OVERDOSE1 reports
ADMINISTRATION SITE PAIN1 reports
ADMINISTRATION SITE SWELLING1 reports
AGEUSIA1 reports
ALLERGY TO ARTHROPOD STING1 reports
ARTHRALGIA1 reports
ARTHRITIS1 reports
ARTHROPOD BITE1 reports
BACK PAIN1 reports
BLOOD GLUCOSE INCREASED1 reports
BLOOD POTASSIUM DECREASED1 reports
BLOOD PRESSURE ABNORMAL1 reports
BLOOD SODIUM DECREASED1 reports
BRONCHIECTASIS1 reports
BURNING SENSATION1 reports
CATHETER SITE ERYTHEMA1 reports
CATHETER SITE PAIN1 reports
CATHETER SITE RELATED REACTION1 reports
CATHETER SITE SWELLING1 reports
CHEST DISCOMFORT1 reports
CHEST PAIN1 reports
CHILLS1 reports
CHOLECYSTECTOMY1 reports
CHRONIC SINUSITIS1 reports
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR1 reports
CLUSTER HEADACHE1 reports
COLD URTICARIA1 reports
CONJUNCTIVITIS1 reports
CONSTIPATION1 reports
CONTUSION1 reports
CYSTITIS1 reports
DEATH1 reports
DEHYDRATION1 reports
DELIRIUM1 reports
DEVICE DELIVERY SYSTEM ISSUE1 reports
DEVICE RELATED THROMBOSIS1 reports
DISORIENTATION1 reports
DISTURBANCE IN ATTENTION1 reports
DRUG HYPERSENSITIVITY1 reports
DRUG INEFFECTIVE1 reports
DRUG INTERACTION1 reports
DRUG WITHDRAWAL SYNDROME1 reports
DYSPEPSIA1 reports
DYSPHAGIA1 reports
DYSPHONIA1 reports
DYSSTASIA1 reports
DYSURIA1 reports
EAR CONGESTION1 reports
EAR PAIN1 reports
ECZEMA1 reports
EPISTAXIS1 reports

Report Outcomes

Out of 61 classified reports for GUAIFENESIN, DEXTROMETHORPHAN HBR:

Serious 39.3%Non-Serious 60.7%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female32 (58.2%)
Male23 (41.8%)

Reports by Age

Age 623 reports
Age 643 reports
Age 653 reports
Age 663 reports
Age 532 reports
Age 582 reports
Age 592 reports
Age 692 reports
Age 712 reports
Age 842 reports
Age 271 reports
Age 281 reports
Age 291 reports
Age 321 reports
Age 331 reports
Age 351 reports
Age 361 reports
Age 421 reports
Age 461 reports
Age 511 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with GUAIFENESIN, DEXTROMETHORPHAN HBR?

This profile reflects 199 FDA FAERS reports that mention GUAIFENESIN, DEXTROMETHORPHAN HBR. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for GUAIFENESIN, DEXTROMETHORPHAN HBR?

Frequently reported terms in FAERS include COVID-19, DYSPNOEA, DISEASE RECURRENCE, ASTHENIA, COUGH, PNEUMONIA. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures GUAIFENESIN, DEXTROMETHORPHAN HBR?

Labeling and FAERS entries often list CVS Pharmacy in connection with GUAIFENESIN, DEXTROMETHORPHAN HBR. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.